<DOC>
	<DOCNO>NCT00144274</DOCNO>
	<brief_summary>The purpose trial investigate efficacy tolerability lozenges contain 20mg broxol hydrochloride relative placebo relieve pain sore throat adolescent patient suf fering acute viral pharyngitis . The primary endpoint time-weighted average pain intensity difference pre-dose ba eline first 3 hour first lozenge express ratio pre-dose baseline ( SPIDnorm ) .</brief_summary>
	<brief_title>Ambroxol Lozenges 20mg Relieving Pain Sore Throat Adolescent Patients With Acute Viral Pharyngitis</brief_title>
	<detailed_description>The purpose trial investigate efficacy tolerability lozenges contain 20mg broxol hydrochloride relative placebo relieve pain sore throat adolescent patient suf fering acute viral pharyngitis . The pain intensity assess patient 6-point rating scale take first lozenge 30 , 60 , 120 180 minute thereafter . The patient enters rating patient 's diary . Study Hypothesis : It test whether statistically significant difference exist S PIDnorm intake 1st lozenge group treat ambro xol lozenge group treat placebo lozenge . Comparison ( ) : Placebo comparison</detailed_description>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Ambroxol</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Patients sore throat acute viral pharyngitis . 2 . Female male patient 12 less 18 year age . 3 . The throat pain intensity rat least `` moderate '' VRS ( PI ) . 4 . Written Informed Consent give patient 's parent/legal guardian , patient able give Assent . 5 . Compliance patient seem guarantee , patient seem able understand complete patient diary . 6 . Patient able remain doctor 's practice initial 3 hour follo wing first intake study medication , know reliable patient , able return study visit . EXCLUSION CRITERIA 1 . Female patient begin menstruate : 1 . Pregnant 2 . Currently breastfeed 3 . Of childbearing potential NOT practice acceptable method birth control , NOT plan continue practice acceptable method throughout study . Acceptable method birth control include surgical sterilisation , intra uterine device , oral , implantable injectable contraceptive . Abstinenc e use contraception , discretion investigator . 2 . Patients symptoms primarily bacterial pharyngitis bacterial secon dary infection ( clinical finding inter alia assessment exudate ) . 3 . First indication symptom acute pharyngitis ( e.g . sore throat ) occurre 3 day ago . 4 . Patients suffer acute viral bacterial pharyngitis past 4 week . 5 . Patient past week , study require treatment following : antibiotic analgesic antiinflammatory agent steroid fo r oral , inhale topical application expectorant antitussives . No phys ical therapy ( e.g . throat compress ) may apply trial . 6 . Patients mouth breathe result nasal congestion . 7 . Known hypersensitivity Ambroxol auxiliary substance contain lozenge . 8 . Previous and/or exist tumour condition . 9 . Alcohol , and/or drug abuse . 10 . Any clinical condition , opinion investigator would llow safe completion protocol safe administration trial medication . 11 . Any investigational therapy within 30 day prior randomisation .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>